The impact of ionizing radiation compared to drug-induced immunological changes.
Soha M HussienPublished in: Canadian journal of physiology and pharmacology (2023)
Ionizing radiation (IR) activates several signaling pathways. This study shows the impact of acute low-dose IR on crucial cytokines involved in cell-mediated immunity. The immunomodulatory effects of 0.25 and 0.5 Gray (Gy) gamma rays and standard immunomodulatory drugs (cyclophosphamide) on blood counts and significant pro-inflammatory cytokines implicated in various inflammatory conditions were tested in 20 rats. Examined was the effect of acute low doses on critical cytokines, which could be utilized as an alternative to current immunosuppressive drugs. One day post-irradiation, serum levels of interferon-gamma (INF-γ), tumor necrosis factor-alpha, and interleukin-2/1-beta were measured. A 0.25 Gy exposure did not affect the detected cytokines or blood cell count compared to the nonirradiated group. On the other hand, 0.5 Gy raises the majority of the immunologically examined cytokines except for INF-γ. Except for INF-γ, cyclophosphamide reduces all of the cytokines examined. As a result, low-dose IR has a less negative influence on essential inflammatory cytokines, permitting its use. More research is needed to determine how low amounts could be used in different immunological disorders.
Keyphrases
- drug induced
- low dose
- liver injury
- high dose
- liver failure
- single cell
- signaling pathway
- cell therapy
- rheumatoid arthritis
- peripheral blood
- oxidative stress
- stem cells
- radiation therapy
- intensive care unit
- epithelial mesenchymal transition
- hepatitis b virus
- aortic dissection
- cell proliferation
- anti inflammatory
- radiation induced
- immune response
- extracorporeal membrane oxygenation
- endoplasmic reticulum stress